2nd Quarter - Report
DAVITA INC. for DAVITA INC
Firm
Client
Income
—
Expenses
$930,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
End-stage renal disease reimbursement and policies contained in the End-Stage Renal Disease Prospective Payment System Proposed Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA; Rep Minge LD |
Veterans VET
Proposed Rule relating to payments for non-departmental facilities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA; Rep Minge LD |
Health Issues HCR
End-stage renal disease reimbursement and policies contained in the End-Stage Renal Disease Prospective Payment System Proposed Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA; Rep Minge LD |
Medicare/Medicaid MMM
End-stage renal disease reimbursement and policies contained in the End-Stage Renal Disease Prospective Payment System Proposed Rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| JOHN SCHAEFFLER | Rep Sikorski LA; Rep Minge LD |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.